Updated Jul 16, 2026
Scalzo Richard William has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $138K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | CBIO | CRESCENT BIOPHARMA, INC. | S — Open-market sale | 1.1K | $17.99 | $20K |
| 2024-12-11 | DYN | Dyne Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.5K | $28.12 | $41K |
| 2024-12-06 | DYN | Dyne Therapeutics, Inc. | A — Grant or award | 32.7K | $0.00 | |
| 2024-11-18 | DYN | Dyne Therapeutics, Inc. | S — Open-market sale [10b5-1] | 2.7K | $28.20 | $77K |
Scalzo Richard William is a corporate insider — currently tracked as Chief Financial Officer of CRESCENT BIOPHARMA, INC. (CBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($138K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Scalzo Richard William profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.